FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2

FASEB Journal

Volumn 27, Issue 4, 2013, Pages 1439-1449

  Okamoto, Ryuji ^a,b   Li, Yuxin ^a   Noma, Kensuke ^a   Hiroi, Yukio ^a   Liu, Ping Yen ^a   Taniguchi, Masaya ^b   Ito, Masaaki ^b   Liao, James K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin; Extracellular regulated signaling kinase; Four and a half limonly protein; Rho kinase; Serum response factor

Indexed keywords

ANGIOTENSIN II; CRE RECOMBINASE; FOUR AND A HALF LIM ONLY PROTEIN 2; LIM PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MYOSIN HEAVY CHAIN ALPHA; RHO ASSOCIATED COILED COIL CONTAINING KINASE 2; RHO KINASE; SERUM RESPONSE FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; APOPTOSIS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE SILENCING; HAPLOINSUFFICIENCY; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HEMODYNAMIC PARAMETERS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE;

ANGIOTENSIN II; ANIMALS; CARDIOMEGALY; FIBROSIS; HEART; LIM-HOMEODOMAIN PROTEINS; MALE; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE PROTEINS; MYOCYTES, CARDIAC; RHO-ASSOCIATED KINASES; TRANSCRIPTION FACTORS; UP-REGULATION;

MUS; MUS MUSCULUS;

EID: 84875728071     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-217018     Document Type: Article

References (44)

1. Aoki, H., Izumo, S., and Sadoshima, J. (1998) Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation. Circ. Res. 82, 666-676.
2. Aikawa, R., Komuro, I., Yamazaki, T., Zou, Y., Kudoh, S., Zhu, W., Kadowaki, T., and Yazaki, Y. (1999) Rho family small G proteins play critical roles in mechanical stress-induced hypertrophic responses in cardiac myocytes. Circ. Res. 84, 458-466.
3. Takemoto, M., Node, K., Nakagami, H., Liao, Y., Grimm, M., Takemoto, Y., Kitakaze, M., and Liao, J. K. (2001) Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J. Clin. Invest. 108, 1429-1437.
4. Satoh, M., Ogita, H., Takeshita, K., Mukai, Y., Kwiatkowski, D. J., and Liao, J. K. (2006) Requirement of Rac1 in the development of cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 103, 7432-7437.
5. Lim, L., Manser, E., Leung, T., and Hall, C. (1996) Regulation of phosphorylation pathways by p21 GTPases. The p21 Rasrelated Rho subfamily and its role in phosphorylation signalling pathways. Eur. J. Biochem. 242, 171-185.
6. Kaibuchi, K., Kuroda, S., and Amano, M. (1999) Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu. Rev. Biochem. 68, 459-486.
7. Narumiya, S., Ishizaki, T., and Watanabe, N. (1997) Rho effectors and reorganization of actin cytoskeleton. FEBS Lett. 410, 68-72.
8. Riento, K., and Ridley, A. J. (2003) Rocks: multifunctional kinases in cell behaviour. Nat. Rev. 4, 446-456.
9. Shimokawa, H., and Takeshita, A. (2005) Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler. Thromb. Vasc. Biol. 25, 1767-1775.
10. Chrissobolis, S., and Sobey, C. G. (2006) Recent evidence for an involvement of rho-kinase in cerebral vascular disease. Stroke 37, 2174-2180.
11. Noma, K., Oyama, N., and Liao, J. K. (2006) Physiological role of ROCKs in the cardiovascular system. Am. J. Physiol. Cell Physiol. 290, C661-C668.
12. Rikitake, Y., Kim, H. H., Huang, Z., Seto, M., Yano, K., Asano, T., Moskowitz, M. A., and Liao, J. K. (2005) Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke 36, 2251-2257.
13. Kong, Y., Shelton, J. M., Rothermel, B., Li, X., Richardson, J. A., Bassel-Duby, R., and Williams, R. S. (2001) Cardiac-specific LIM protein FHL2 modifies the hypertrophic response to betaadrenergic stimulation. Circulation 103, 2731-2738.
14. Chu, P. H., Bardwell, W. M., Gu, Y., Ross, J., Jr., and Chen, J. (2000) FHL2 (SLIM3) is not essential for cardiac development and function. Mol. Cell. Biol. 20, 7460-7462.
15. Johannessen, M., Moller, S., Hansen, T., Moens, U., and Van Ghelue, M. (2006) The multifunctional roles of the four-and-ahalf- LIM only protein FHL2. Cell. Mol. Life Sci. 63, 268-284.
16. Purcell, N. H., Darwis, D., Bueno, O. F., Muller, J. M., Schule, R., and Molkentin, J. D. (2004) Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes. Mol. Cell. Biol. 24, 1081-1095.
17. Philippar, U., Schratt, G., Dieterich, C., Muller, J. M., Galgoczy, P., Engel, F. B., Keating, M. T., Gertler, F., Schule, R., Vingron, M., and Nordheim, A. (2004) The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF. Mol. Cell. 16, 867-880.
18. Agah, R., Frenkel, P. A., French, B. A., Michael, L. H., Overbeek, P. A., and Schneider, M. D. (1997) Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J. Clin. Invest. 100, 169-179.
19. Noma, K., Rikitake, Y., Oyama, N., Yan, G., Alcaide, P., Liu, P. Y., Wang, H., Ahl, D., Sawada, N., Okamoto, R., Hiroi, Y., Shimizu, K., Luscinskas, F. W., Sun, J., and Liao, J. K. (2008) ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury. J. Clin. Invest. 118, 1632-1644.
20. Rikitake, Y., Oyama, N., Wang, C. Y., Noma, K., Satoh, M., Kim, H. H., and Liao, J. K. (2005) Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice. Circulation 112, 2959-2965.
21. Zhang, X., Azhar, G., Chai, J., Sheridan, P., Nagano, K., Brown, T., Yang, J., Khrapko, K., Borras, A. M., Lawitts, J., Misra, R. P., and Wei, J. Y. (2001) Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am. J. Physiol. 280, H1782-H1792.
22. Thumkeo, D., Shimizu, Y., Sakamoto, S., Yamada, S., and Narumiya, S. (2005) ROCK-I and ROCK-II cooperatively regulate closure of eyelid and ventral body wall in mouse embryo. Genes Cells 10, 825-834.
23. Yamaguchi, Y., Katoh, H., and Negishi, M. (2003) N-terminal short sequences of alpha subunits of the G12 family determine selective coupling to receptors. J. Biol. Chem. 278, 14936-14939.
24. Hartshorne, D. J., Ito, M., and Erdodi, F. (2004) Role of protein phosphatase type 1 in contractile functions: myosin phosphatase. J. Biol. Chem. 279, 37211-37214.
25. Fielitz, J., van Rooij, E., Spencer, J. A., Shelton, J. M., Latif, S., van der Nagel, R., Bezprozvannaya, S., de Windt, L., Richardson, J. A., Bassel-Duby, R., and Olson, E. N. (2007) Loss of musclespecific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction. Proc. Natl. Acad. Sci. U. S. A. 104, 4377-4382.
26. Higashi, M., Shimokawa, H., Hattori, T., Hiroki, J., Mukai, Y., Morikawa, K., Ichiki, T., Takahashi, S., and Takeshita, A. (2003) Long-term inhibition of Rho-kinase suppresses angiotensin IIinduced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ. Res. 93, 767-775.
27. Hattori, T., Shimokawa, H., Higashi, M., Hiroki, J., Mukai, Y., Tsutsui, H., Kaibuchi, K., and Takeshita, A. (2004) Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice. Circulation 109, 2234-2239.
28. Wang, Y. X., da Cunha, V., Martin-McNulty, B., Vincelette, J., Li, W., Choy, D. F., Halks-Miller, M., Mahmoudi, M., Schroeder, M., Johns, A., Light, D. R., and Dole, W. P. (2005) Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice. Eur. J. Pharmacol. 512, 215-222.
29. Zhang, Y. M., Bo, J., Taffet, G. E., Chang, J., Shi, J., Reddy, A. K., Michael, L. H., Schneider, M. D., Entman, M. L., Schwartz, R. J., and Wei, L. (2006) Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis. FASEB J. 20, 916-925.
30. Rikitake, Y., and Liao, J. K. (2005) Rho-kinase mediates hyperglycemia- induced plasminogen activator inhibitor-1 expression in vascular endothelial cells. Circulation 111, 3261-3268.
31. Shi, J., Zhang, Y. W., Summers, L. J., Dorn, G. W., 2nd and Wei, L. (2008) Disruption of ROCK1 gene attenuates cardiac dilation and improves contractile function in pathological cardiac hypertrophy. J. Mol. Cell. Cardiol. 44, 551-560.
32. Parlakian, A., Charvet, C., Escoubet, B., Mericskay, M., Molkentin, J. D., Gary-Bobo, G., De Windt, L. J., Ludosky, M. A., Paulin, D., Daegelen, D., Tuil, D., and Li, Z. (2005) Temporally controlled onset of dilated cardiomyopathy through disruption of the SRF gene in adult heart. Circulation 112, 2930-2939.
33. Miano, J. M., Long, X., and Fujiwara, K. (2007) Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am. J. Physiol. Cell Physiol. 292, C70-C81.
34. Hill, C. S., Wynne, J., and Treisman, R. (1995) The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81, 1159-1170.
35. Sotiropoulos, A., Gineitis, D., Copeland, J., and Treisman, R. (1999) Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 98, 159-169.
36. Nakano, K., Takaishi, K., Kodama, A., Mammoto, A., Shiozaki, H., Monden, M., and Takai, Y. (1999) Distinct actions and cooperative roles of ROCK and mDia in Rho small G proteininduced reorganization of the actin cytoskeleton in Madin- Darby canine kidney cells. Mol. Biol. Cell 10, 2481-2491.
37. Miralles, F., Posern, G., Zaromytidou, A. I., and Treisman, R. (2003) Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113, 329-342.
38. Kuwahara, K., Barrientos, T., Pipes, G. C., Li, S., and Olson, E. N. (2005) Muscle-specific signaling mechanism that links actin dynamics to serum response factor. Mol. Cell. Biol. 25, 3173-3181.
39. Chang, D. F., Belaguli, N. S., Iyer, D., Roberts, W. B., Wu, S. P., Dong, X. R., Marx, J. G., Moore, M. S., Beckerle, M. C., Majesky, M. W., and Schwartz, R. J. (2003) Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors. Dev. Cell 4, 107-118.
40. Muller, J. M., Metzger, E., Greschik, H., Bosserhoff, A. K., Mercep, L., Buettner, R., and Schule, R. (2002) The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus. EMBO J. 21, 736-748.
41. Nishiyama, T., Kii, I., and Kudo, A. (2004) Inactivation of Rho/ROCK signaling is crucial for the nuclear accumulation of FKHR and myoblast fusion. J. Biol. Chem. 279, 47311-47319.
42. Hoshijima, M. (2006) Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures. Am. J. Physiol. Heart Circ. Physiol. 290, H1313-H1325.
43. Powell, S. R. (2006) The ubiquitin-proteasome system in cardiac physiology and pathology. Am. J. Physiol. Heart Circ. Physiol. 291, H1-H19.
44. Lange, S., Auerbach, D., McLoughlin, P., Perriard, E., Schafer, B. W., Perriard, J. C., and Ehler, E. (2002) Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2. J. Cell Sci. 115, 4925-4936.